IP Library Assignment 028192/0789
Patent Assignment
Reel/Frame 028192/0789

Change of Name

Recorded: 2012-05-10 Pages: 5
Assignor
ANGIOBLAST SYSTEMS, INC.
Executed: 2011-09-30
Assignee
MESOBLAST, INC.
275 MADISON AVE, 4TH FLOOR, NEW YORK, NEW YORK, 10016
Covered Properties (21)
Mesenchymal Precursor Cell
Patent: 7,122,178 →
Application: 10/030,411 →
Perivascular Mesenchymal Precursor Cells
Patent: 7,947,266 →
Application: 10/551,162 →
Publication: US 2007/0065938
Perivascular Mesenchymal Precursor Cell Induced Blood Vessel Formation
Patent: 9,169,466 →
Application: 10/551,326 →
Publication: US 2006/0286077
Mesenchymal Precursor Cell
Patent: 7,670,628 →
Application: 10/813,747 →
Publication: US 2005/0019911
Mesenchymal Precursor Cell
Patent: 8,158,118 →
Application: 11/169,875 →
Publication: US 2005/0281790
Mesenchymal Precursor Cell
Patent: 7,399,632 →
Application: 11/178,920 →
Publication: US 2006/0008452
Perivascular mesenchymal precursor cell induced blood vessel formation
Patent: 9,175,267 →
Application: 11/326,736 →
Publication: US 2006/0193840
Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof
Application: 11/663,563 →
Publication: US 2008/0260694
Isolation of Adult Multipotential Cells by Tissue Non-Specific Alkaline Phosphatase
Patent: 8,367,405 →
Application: 11/918,593 →
Publication: US 2009/0074728
Treatment of excessive neovascularization
Application: 12/309,158 →
Publication: US 2010/0111910
Methods of Generating, Repairing and/or Maintaining Connective Tissue in Vivo
Patent: 9,381,216 →
Application: 12/452,767 →
Publication: US 2010/0203020
Mesenchymal Precursor Cell
Patent: 8,062,675 →
Application: 12/660,003 →
Publication: US 2010/0330045
Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC)
Application: 12/924,008 →
Publication: US 2011/0223668
Repair and/or Reconstitution of Invertebral Discs
Patent: 8,858,932 →
Application: 13/000,721 →
Publication: US 2011/0189138
Treatment of Eye Diseases and Excessive Neovascularization Using Combined Therapy
Application: 13/002,229 →
Publication: US 2011/0200612
Monoclonal Antibody Stro-4
Patent: 9,090,678 →
Application: 13/059,448 →
Publication: US 2011/0189696
Expansion of Haemopoietic Precursors
Patent: 8,828,375 →
Application: 13/061,693 →
Publication: US 2011/0217263
Perivascular Mesenchymal Precursor Cells
Application: 13/098,892 →
Publication: US 2012/0082649
Method for Treating or Preventing a Pancreatic Dysfunction
Patent: 8,894,972 →
Application: 13/129,180 →
Publication: US 2011/0243902
Production of Reprogrammed Pluripotent Cells
Patent: 9,487,756 →
Application: 13/257,233 →
Publication: US 2012/0121548
Mesenchymal Precursor Cell
Patent: 8,546,138 →
Application: 13/270,863 →
Publication: US 2012/0276553
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 22, 2010
From: RAKOCZY, PIROSKA ELIZABETH
To: VISOGENE PTY LTD
Reel/Frame 023841/0651 →
Assignment of Assignor's Interest Jan 22, 2010
From: VISOGENE PTY LTD
To: ANGIOBLAST SYSTEMS, INC.
Reel/Frame 023842/0473 →
Intellectual Property Security Agreement Mar 28, 2018
From: MESOBLAST, INC.
To: HERCULES CAPITAL, INC., AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 045759/0682 →
Security Interest Dec 10, 2021
From: MESOBLAST LIMITED ACN 109 431 870; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 058957/0447 →
Release of Intellectual Property Security Agreement at Reel/Frame No. 45759/0682 Jul 30, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: MESOBLAST, INC.
Reel/Frame 072294/0555 →
Release of Security Interest in Intellectual Property Jan 2, 2026
From: OAKTREE FUND ADMINISTRATION, LLC, AS AGENT
To: MESOBLAST LIMITED; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 074174/0183 →